Tirzepatide 3-month weight loss progress: what the data says

What did @koakley2024 actually say?

Pretty straightforward: this creator shared their medical records showing a weight drop from 319.67 pounds down to 282 pounds over roughly three and a half to four months on tirzepatide (Zepbound). That works out to a 37-pound loss, which they called "insane" progress. They also noted their home scale reads about four to five pounds lighter than the clinic scale, which is a real and common discrepancy worth flagging.

No wild claims here. No promises of a cure, no specific dose recommendations, no before-and-after photo manipulation. Just someone reading a graph from their actual medical record and doing the math out loud. The transparency is refreshing compared to a lot of GLP-1 content on TikTok.

Does the science back this up?

Yes, and then some. A 37-pound loss over roughly 16 weeks is aggressive but entirely consistent with what clinical trials have shown for tirzepatide at higher doses.

The SURMOUNT-1 trial (Jastreboff et al., 2022, New England Journal of Medicine) is the key reference here. In that study, participants on 15 mg tirzepatide lost an average of 20.9% of body weight over 72 weeks. Early responders in those trials can see substantial losses in the first few months, particularly during dose escalation when appetite suppression tends to be strongest.

For someone starting at 319 pounds, a 37-pound loss represents about 11.6% of starting body weight over four months. That tracks with real-world data. A 2023 analysis by Frias et al. in Diabetes Care found that tirzepatide's dual GIP and GLP-1 receptor agonism produces faster early weight loss compared to semaglutide monotherapy, which helps explain why results in the first three to four months can look dramatic.

So the numbers are not exaggerated. If anything, they are representative of what a good early responder looks like on this medication.

What did they get wrong (or right)?

They got the core claim right. The weight loss figure appears to come directly from a medical record, which is about as credible a source as a patient can cite. No embellishment detected.

The one thing worth addressing: they mention their "starting weight before the tres appetite," which is clearly a speech-recognition or informal shorthand for tirzepatide. The implication is that 319.67 was their weight at the time they started the drug. But they also note they were "a little bit higher before" that reading. This matters because the starting point affects how you calculate total percentage loss. If their true pre-treatment peak was above 319, the percentage loss could be slightly lower than it appears on that graph.

That is a minor point, not a deception. But if you are comparing your own progress to theirs, use your own documented start weight, not a retrospective estimate.

What they got right: acknowledging the home-scale discrepancy. Clinic scales are typically calibrated and measured under controlled conditions (shoes off, consistent time of day). Home scales vary. Pointing that out without trying to game the numbers is honest.

What should you actually know?

This video is a personal progress update, not a clinical recommendation, and that distinction matters.

Individual results on tirzepatide vary significantly based on starting dose, titration schedule, diet, activity level, and metabolic factors that no TikTok video can account for. The SURMOUNT-1 trial showed a wide range of outcomes even under controlled conditions. Some participants lost over 25% of body weight; others lost closer to 5%. Comparing your month three to someone else's month three is not a useful exercise.

There is also the question of what happens after the early rapid-loss phase. Weight loss typically slows as the body adapts and as patients approach a new set point. The first four months on tirzepatide often produce the steepest part of the curve. That does not mean progress stops, but it does mean the 37-pound-in-four-months pace is unlikely to continue indefinitely.

If you are considering tirzepatide or are already on it, the right benchmark is your own medical record, not a TikTok graph. Work with a licensed prescriber who can monitor your labs, adjust dosing appropriately, and track progress over time.